JNJ

2026Q1BMO

Johnson & Johnson primary · HEALTHCARE · DRUG MANUFACTURERS - GENERAL

Report 2026-04-14 · Fiscal end 2026-03-31 · Features as of 2026-04-13

← Earnings history

Pre-Earnings Data

Expectations & setup

Street

Consensus EPS2.68
Consensus rev—
EPS high—
EPS low—
Dispersion—
Analysts—
EPS rev net 7d—
EPS rev net 30d—
Consensus Δ 7d—
Consensus Δ 30d—

Options

Implied move2.2%
IV front—
P/C full—
P/C front—
Features as of2026-04-13

Run-up

Close—
Ret 5d-1.2%
Ret 10d-1.0%
Ret 20d-1.5%
Ret 30d-4.2%

Post-Earnings Data

Results & reaction

Print

Actual EPS
2.70Beat
Estimated EPS2.68
Actual revenue
24.1B
Surprise %+0.7%
Beat / missBeat
Beat streak 41
Beat streak 81

Reaction

1-day stock reaction+2.2%
Implied vs actual

Implied 2.2%Actual 1.2%

Gap reaction-1.2%
Day result+0.9%
Next-day upYes
Realized / IV0.56×

Post tape

Post 5d-5.8%
Post 10d-5.1%
Post volume10.3M
Vol ×10d1.50×
Vol ×20d1.37×
Post range3.8%